Literature DB >> 20413965

Vascular calcification in animal models of CKD: A review.

Navid Shobeiri1, Michael A Adams, Rachel M Holden.   

Abstract

Vascular calcification is a significant contributor to the cardiovascular mortality observed in chronic kidney disease (CKD). This review discusses the animal models (5/6 nephrectomy, mouse electrocautery model and dietary adenine) that have been employed in the study of vascular calcification outcomes in CKD. Rodent models of CKD generate a range of severity in the vascular calcification phenotype. Major limitations of the 5/6th nephrectomy model include the requirement for surgery and the need to use either excessive dietary phosphorus or vitamin D. Major limitations of the mouse electrocautery model include the requirement for surgery, the mortality rate when very advanced CKD develops, and resistance to vascular calcification without the use of transgenic animals. This is balanced against the major advantage of the ability to study transgenic animals to further understand the mechanisms associated with either the acceleration or inhibition of calcification. Dietary adenine generates severe CKD and does not require surgery. The major disadvantage is the weight loss that ensues when rats receive a diet containing 0.75% adenine. In summary, animal models are useful to study CKD-associated vascular calcification and the results obtained in these pre-clinical animal studies appear to translate to the evidence, however limited, which exists in humans with CKD. 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20413965     DOI: 10.1159/000299794

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  43 in total

1.  Phylloquinone and vitamin D status: associations with incident chronic kidney disease in the Framingham Offspring cohort.

Authors:  Conall M O'Seaghdha; Shih-Jen Hwang; Rachel Holden; Sarah L Booth; Caroline S Fox
Journal:  Am J Nephrol       Date:  2012-06-20       Impact factor: 3.754

Review 2.  Renal organic anion transporters (SLC22 family): expression, regulation, roles in toxicity, and impact on injury and disease.

Authors:  Li Wang; Douglas H Sweet
Journal:  AAPS J       Date:  2012-10-09       Impact factor: 4.009

3.  The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease.

Authors:  Matthew J Williams; Toshifumi Sugatani; Olga A Agapova; Yifu Fang; Joseph P Gaut; Marie-Claude Faugere; Hartmut H Malluche; Keith A Hruska
Journal:  Kidney Int       Date:  2017-08-23       Impact factor: 10.612

Review 4.  Chronic kidney disease-associated cardiovascular disease: scope and limitations of animal models.

Authors:  Omid Sadeghi-Alavijeh; Mohammad Tadayyon; Ben Caplin
Journal:  Cardiovasc Endocrinol       Date:  2017-11-15

5.  Inducible podocyte-specific deletion of CTCF drives progressive kidney disease and bone abnormalities.

Authors:  Marta Christov; Abbe R Clark; Braden Corbin; Samy Hakroush; Eugene P Rhee; Hiroaki Saito; Dan Brooks; Eric Hesse; Mary Bouxsein; Niels Galjart; Ji Yong Jung; Peter Mundel; Harald Jüppner; Astrid Weins; Anna Greka
Journal:  JCI Insight       Date:  2018-02-22

6.  Effect of cross-linked chitosan iron (III) on vascular calcification in uremic rats.

Authors:  Barbara Bruna Abreu de Castro; Wander Barros do Carmo; Paulo Giovani de Albuquerque Suassuna; Moises Carminatti; Julia Bianchi Brito; Wagner Vasques Dominguez; Ivone Braga de Oliveira; Vanda Jorgetti; Melani Ribeiro Custodio; Helady Sanders-Pinheiro
Journal:  Exp Biol Med (Maywood)       Date:  2018-05

7.  Calcium-phosphate microprecipitates mimic microparticles when examined with flow cytometry.

Authors:  Michael C Larson; Maia R Luthi; Neil Hogg; Cheryl A Hillery
Journal:  Cytometry A       Date:  2012-11-02       Impact factor: 4.355

Review 8.  Phosphate: an old bone molecule but new cardiovascular risk factor.

Authors:  Navid Shobeiri; Michael A Adams; Rachel M Holden
Journal:  Br J Clin Pharmacol       Date:  2014-01       Impact factor: 4.335

9.  Myeloperoxidase-derived oxidants damage artery wall proteins in an animal model of chronic kidney disease-accelerated atherosclerosis.

Authors:  Lixia Zeng; Anna V Mathew; Jaeman Byun; Kevin B Atkins; Frank C Brosius; Subramaniam Pennathur
Journal:  J Biol Chem       Date:  2018-03-26       Impact factor: 5.157

10.  Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation.

Authors:  Caitlin O'Rourke; Georgia Shelton; Joshua D Hutcheson; Megan F Burke; Trejeeve Martyn; Timothy E Thayer; Hannah R Shakartzi; Mary D Buswell; Robert E Tainsh; Binglan Yu; Aranya Bagchi; David K Rhee; Connie Wu; Matthias Derwall; Emmanuel S Buys; Paul B Yu; Kenneth D Bloch; Elena Aikawa; Donald B Bloch; Rajeev Malhotra
Journal:  J Vis Exp       Date:  2016-05-31       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.